Principal Risks Associated with Intermittent Hemodialysis
The most critical risks of intermittent hemodialysis are intradialytic hypotension (occurring in ~25% of sessions), cardiovascular complications (responsible for at least 50% of deaths), and vascular access-related infections and thrombosis.
Immediate Intradialytic Risks
Intradialytic Hypotension (IDH)
IDH represents the most common acute complication, defined as a decrease in systolic blood pressure by ≥20 mmHg or MAP by ≥10 mmHg with associated symptoms 1, 2. This occurs because ultrafiltration removes intravascular volume faster than compensatory plasma refilling from the extravascular space can occur 3.
Clinical manifestations include:
- Abdominal discomfort, nausea, vomiting
- Muscle cramps (70% of medical terminations)
- Dizziness, fainting, anxiety
- Feeling sick (48% of premature terminations) 1
High-risk patient subgroups:
- Diabetic patients with autonomic dysfunction
- Elderly patients (≥65 years)
- Pre-dialysis systolic BP <100 mmHg
- Patients with cardiovascular disease or left ventricular hypertrophy
- Poor nutritional status with hypoalbuminemia 2
IDH is not merely a transient inconvenience—it directly increases mortality risk. In patients with acute kidney injury requiring intermittent hemodialysis, IDH occurrence was associated with 30% higher mortality (HR 1.30) and 43% higher ICU transfer rates (HR 1.43) 4.
Cardiovascular Complications During Dialysis
Dysrhythmias occur frequently:
- Ventricular dysrhythmias in 76% of maintenance dialysis patients
- Potentially life-threatening ventricular dysrhythmias in 29% of patients
- Atrial dysrhythmias in 10% of patients 2
The dysrhythmogenic risk stems from rapid electrolyte shifts (potassium, calcium, magnesium), volume changes, and myocardial stunning that occurs independent of ultrafiltration 3. Patients with pre-existing coronary artery disease, left ventricular hypertrophy, or prolonged QTc intervals face substantially elevated risk 2.
Long-Term Cardiovascular Risks
Cardiovascular disease causes at least 50% of hemodialysis deaths 5. The intermittent nature of thrice-weekly hemodialysis creates a fundamentally unphysiologic state with dramatic fluctuations in volume, metabolites, and electrolytes 6.
Hypertension and Volume Overload
Between 60-90% of maintenance hemodialysis patients develop hypertension 5. The pathogenesis is multifactorial:
- Fluid overload from sodium and water retention (primary mechanism)
- Arterial stiffness from arteriosclerosis
- Sympathetic nervous system overactivity
- Renin-angiotensin system activation 5
Critically, only 30% of hypertensive dialysis patients achieve adequate blood pressure control, while 12% receive no treatment at all 5. This inadequate control perpetuates left ventricular hypertrophy and increases cardiovascular mortality risk.
Myocardial Ischemia
Repeated episodes of IDH cause organ hypoperfusion with cumulative ischemic damage to the heart, brain, and gut 7. This "repetitive stunning" contributes to progressive cardiac dysfunction and increased long-term mortality.
Vascular Access Complications
Infection Risk
Vascular access infections represent a major source of morbidity, with infection being the second leading cause of death in hemodialysis patients 8.
Risk factors include:
- Central venous catheter use (highest risk)
- Buttonhole cannulation technique (increased risk of metastatic infections) 9
- Immunocompromised status of dialysis patients
- Multiple cannulations per week 8
The Canadian Society of Nephrology guidelines specifically recommend rope-ladder cannulation over buttonhole unless topical mupirocin prophylaxis is used, due to infection concerns 10.
Access Thrombosis and Dysfunction
Intradialytic hypotension episodes predispose to vascular access thrombosis 2. When Qa (access flow) falls below 450-500 mL/min in arteriovenous fistulas, intervention is warranted to prevent thrombosis 11. Up to 90% of patients with abnormal physical examination findings demonstrate hemodynamically significant abnormalities requiring intervention 11.
Inadequate Dialysis Delivery
IDH directly compromises dialysis adequacy through multiple mechanisms:
- Premature treatment termination (55% of early terminations are medical, predominantly from cramps and hypotension) 1
- Reduced blood flow rates when hypotension occurs
- Failure to achieve ultrafiltration goals
- Exaggerated urea rebound from protracted hypotension 1
This creates a vicious cycle where inadequate dialysis perpetuates volume overload, worsening subsequent hypotension risk.
Electrolyte and Metabolic Disturbances
The intermittent nature of hemodialysis creates wide fluctuations in:
- Potassium levels (between-session accumulation)
- Calcium and phosphate balance
- Acid-base status
- Volume status 2
These fluctuations contribute to dysrhythmogenicity and metabolic instability. For intensive hemodialysis regimens specifically, hypophosphatemia and negative calcium balance can occur, requiring dialysate adjustments 10.
Patient Burden and Non-Adherence
Physical discomfort from dialysis treatments leads to:
- Missed sessions
- Late arrivals
- Premature treatment termination
- Overall non-adherence 1
This non-adherence further compromises delivered dialysis dose and worsens outcomes, creating another negative feedback loop.
Critical Monitoring Priorities
To mitigate these risks, focus on:
- Pre-dialysis assessment: Identify high-risk patients (diabetics, elderly, cardiovascular disease, pre-dialysis SBP <100 mmHg)
- Baseline ECG: Obtain 12-lead ECG at dialysis initiation to identify dysrhythmia risk 2
- Vascular access surveillance: Monitor for physical examination abnormalities, measure Qa when indicated 11
- Infection screening: Screen all incident patients for HBV, HCV, and HIV; vaccinate appropriately 8
- Volume status: Reassess dry weight regularly, particularly when recurrent hypotension occurs 1, 5
The evidence consistently demonstrates that intermittent hemodialysis, while life-sustaining, carries substantial cardiovascular, infectious, and hemodynamic risks that require vigilant monitoring and proactive management to optimize patient outcomes.